CPX-351 improves outcomes for refractory AML
CPX-351 improves outcomes for refractory AML
ASCO 2016: Plenary Session Review
Novel daratumumab-based regimen slows multiple myeloma progression
Liquid biopsy may help guide treatment decisions for advanced solid tumours
Liquid biopsy may help guide treatment decisions for advanced solid tumours
ASCO 2016: Expert discussion on the latest on multiple myeloma
Hodgkins - update on treatment strategies in children and adolescents
Use of novel agents in childhood ALL
Radiotherapy in Hogkin lymphoma: reducing risk in later life
Relapsed Hodgkin lymphoma in PET positive patients
Treatment of relapsed myeloma with novel targeted and immune therapies
Understanding personalised medicine - the e-learning course